摘要
目的:从医保支付方的角度,评估肾康栓进入国家基本医保目录后,对医保基金可能产生的影响。方法:基于国际药物经济学与结果研究协会公布的预算影响分析指南,采用Excel构建预算影响分析模型。结果:肾康栓纳入医保目录报销后1~5年内,分别节省0. 02、0. 17、0. 35、0. 57、0. 82亿元。结论:肾康栓纳入医保有利于节省医保资金的支出。
Objective:To evaluate the possible impact of shenkangshuan after entering the national basic medical insurance catalogue from the perspective of the medical insurance payment party-. Methods : Based on the budget impact analysis guide published by the International Association for Pharmaeoeeononlies and results research, the budget impact analysis model was built with Excel. Results:After 1 to 5 years of medical insurance reimbursenlent, shenkangshuan can save 0. 02, 0. 17, 0. 35, 0. 57 and 0. 82 million yuan respectively. Conclusion :Shenkangshuan is beneficial to save the expenditure of medical insurance funds.
作者
郜文
GAO Wen(Medical and Health Economic Research Association,Beijing 100069,China)
出处
《中国医药导刊》
2018年第9期556-560,共5页
Chinese Journal of Medicinal Guide
关键词
肾康栓
慢性肾功能衰竭
预算影响分析
Shenkangshuan
Chronic renal failure
Budget impact analysis